Stroke and myocardial infarction with hormonal contraception [5]

New England Journal of Medicine

Volumn 367, Issue 13, 2012, Pages 1264-1265

  Siegel, Arthur J ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CONTRACEPTIVE AGENT; ESTRADIOL; GESTAGEN;

ARTERY THROMBOSIS; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DRUG EFFECT; HEART DISEASE; HEART INFARCTION; HEART PROTECTION; HORMONAL CONTRACEPTION; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; FEMALE; NOTE;

CONTRACEPTIVE AGENTS; ESTRADIOL; FEMALE; HUMANS; MYOCARDIAL INFARCTION; PROGESTINS; STROKE;

EID: 84866745401     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1208930     Document Type: Letter

References (5)

1. Lidegaard Ø, Løkkegaard E, Jensen A, Skovland CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366:2257-66.
2. Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Am Heart J 2011;162(1):115.e2- 124.e2.
3. Petitti DB. Hormonal contraceptives and arterial thrombosis - not risk-free but safe enough. N Engl J Med 2012;366:2316-8.
4. Becattini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012;366:1959-67.
5. Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes. Arch Intern Med 2012;172:209-16.